Haque, A. A. (2026). AN IN-SILICO APPROACH TO REPURPOSE FDA-APPROVED PROPRANOLOL AGAINST PD-L1 PROTEIN TARGET IN CANCER TREATMENT. BME DEPT. MIST.
Cóipeáladh chuig an ngearrthaisce go rathúil é
Níorbh fhéidir cóipeáil chuig an ngearrthaisce
Lua i Stíl Chicago (17ú heag.)
Haque, AKM Arefen. AN IN-SILICO APPROACH TO REPURPOSE FDA-APPROVED PROPRANOLOL AGAINST PD-L1 PROTEIN TARGET IN CANCER TREATMENT. Dhaka: BME DEPT. MIST, 2026.
Cóipeáladh chuig an ngearrthaisce go rathúil é
Níorbh fhéidir cóipeáil chuig an ngearrthaisce
Lua MLA (9ú heag.)
Haque, AKM Arefen. AN IN-SILICO APPROACH TO REPURPOSE FDA-APPROVED PROPRANOLOL AGAINST PD-L1 PROTEIN TARGET IN CANCER TREATMENT. BME DEPT. MIST, 2026.
Cóipeáladh chuig an ngearrthaisce go rathúil é
Níorbh fhéidir cóipeáil chuig an ngearrthaisce
Rabhadh: Seans nach mbeach na luanna seo go hiomlán cruinn i ngach uile chás.